Introduction to GNP MUCUS DM MAX ER
GNP MUCUS DM MAX ER is a medication that combines dextromethorphan, a cough suppressant, and guaifenesin, an expectorant. This combination is commonly used to relieve cough and mucus associated with the common cold and other respiratory infections.
Market Context: Expectorant Drugs
The expectorant drugs market, which includes medications like GNP MUCUS DM MAX ER, is projected to grow steadily. By 2024, the market size is estimated to reach USD 100 million and is expected to increase to USD 120 million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period[3].
Segment Growth: Cough Treatment
The cough treatment segment, where GNP MUCUS DM MAX ER is categorized, is one of the fastest-growing segments within the guaifenesin market. This growth is driven by increasing demand for effective cough and cold medications, particularly in multispecialty hospitals which are the largest end-users of guaifenesin[4].
Price Trends
The prices of GNP MUCUS DM MAX ER can vary based on several factors including the dosage, formulation, and pharmacy.
- Extended Release Formulations: The cost for GNP MUCUS DM MAX ER in extended release formulations can range from approximately $13 to $20 for a supply of 20 tablets, depending on the dosage (30 mg-600 mg or 60 mg-1200 mg)[2][5].
- Price Per Unit: As of recent data, the price per unit for QC MUCUS RELIEF ER (a similar formulation) can range from $0.34521 to $0.47640 per tablet, indicating some variability in pricing[4].
Discounts and Patient Assistance Programs
To make the medication more affordable, several discount options are available:
- Discount Cards: Programs like the Drugs.com Discount Card can save consumers up to 80% on prescription and over-the-counter medications, including GNP MUCUS DM MAX ER[2].
- Coupons and Copay Cards: Although no manufacturer promotions were found specifically for GNP MUCUS DM MAX ER, patients may be able to find printable coupons, rebates, or copay cards through other sources[2].
Patient Assistance Programs
While there are no specific patient assistance programs listed for GNP MUCUS DM MAX ER, patients with low income or those who are uninsured or under-insured may be able to find assistance through other programs offered by healthcare providers or pharmaceutical companies[2].
Safety and Efficacy
The safety and efficacy of GNP MUCUS DM MAX ER are supported by clinical trials and market data. For instance, the voluntary market withdrawal of infant cough and cold medications in 2007 led to a significant reduction in adverse drug events and emergency department visits related to these medications, highlighting the importance of proper labeling and usage[1].
Regional Market Analysis
The largest market for expectorant drugs, including GNP MUCUS DM MAX ER, is North America. However, the Asia Pacific region is expected to be the fastest-growing market during the forecast period, driven by increasing healthcare expenditure and a growing population[3].
Market Concentration
The expectorant drugs market has a medium level of concentration, indicating a balance between a few major players and smaller competitors. This balance can influence pricing strategies and innovation within the market[3].
Key Takeaways
- Market Growth: The expectorant drugs market is expected to grow at a CAGR of 4.5% from 2024 to 2029.
- Price Variability: Prices for GNP MUCUS DM MAX ER can vary based on dosage and pharmacy, with discounts available through various programs.
- Safety and Efficacy: The medication has shown safety and efficacy in clinical trials and real-world use.
- Regional Markets: North America is the largest market, while the Asia Pacific region is the fastest-growing.
- Patient Assistance: Patients may find assistance through discount cards and other programs.
FAQs
Q: What is GNP MUCUS DM MAX ER used for?
A: GNP MUCUS DM MAX ER is used to relieve cough and mucus associated with the common cold and other respiratory infections.
Q: How much does GNP MUCUS DM MAX ER cost?
A: The cost can range from approximately $13 to $20 for a supply of 20 tablets, depending on the dosage and pharmacy.
Q: Are there any discounts available for GNP MUCUS DM MAX ER?
A: Yes, discounts are available through programs like the Drugs.com Discount Card and other coupons or copay cards.
Q: What are the safety implications of using GNP MUCUS DM MAX ER?
A: The medication has shown safety in clinical trials and real-world use, especially after labeling revisions and market withdrawals of similar infant medications.
Q: Which region is expected to be the fastest-growing market for expectorant drugs?
A: The Asia Pacific region is expected to be the fastest-growing market during the forecast period.
Cited Sources
- Cough and Cold Therapeutic Class Review (TCR) - Magellan Rx Management.
- Mucus Relief DM Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com.
- Expectorant Drugs Market Size & Share Analysis - Mordor Intelligence.
- Drug prices and trends for QC MUCUS RELIEF ER - DrugPatentWatch.
- GNP MUCUS RELIEF ER 600MG TAB 20CT - Davis Islands Pharmacy.
